SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-19-000726
Filing Date
2019-05-08
Accepted
2019-05-08 20:06:08
Documents
2
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 8255
2 poacanaan.htm EX-24 15534
  Complete submission text file 0001123292-19-000726.txt   25866
Mailing Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880 203-855-0400
CANAAN X L.P. (Reporting) CIK: 0001619859 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 19808402

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 6508548092
Canaan Partners X LLC (Reporting) CIK: 0001673228 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 19808403